A district judge heard how Brandon Pedryc, 23, typed out ‘Where’s Baldock’ in large letters on his phone and waved it at rival fans.
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also ...